Drugs

The rate of weight loss impacts all-cause mortality in OA patients.

Novo Nordisk’s weekly injection is approved for weight loss among patients diagnosed with obesity.

A U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer.

It's not just physical symptoms: Remember the emotional, cognitive and relational impacts that antidepressant withdrawal can have on your patients.

Aminophylline 25 mg/mL injection will be available from Septa Pharma under Exceptional Import Approval by Health Canada to fulfill the Tier 3 shortage.

Data on diabetes, dermatology and depression and more in this latest report that examines how much drug plans spend on different medications each year.

Can you figure out which statement about this newly approved treatment?